Exvastat Ltd

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Saving lives by defeating ARDS from any cause. Single asset clinical stage company developing repurposed asset. Moving into Phase III
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
United Kingdom
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
Impentri(TM), intravenous imatinib
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
CEO
Exvastat Ltd